TalkMed Group (SGX:5G3) FCF Margin % : 42.63% (As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is TalkMed Group FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. TalkMed Group's Free Cash Flow for the six months ended in Dec. 2023 was S$19.61 Mil. TalkMed Group's Revenue for the six months ended in Dec. 2023 was S$46.00 Mil. Therefore, TalkMed Group's FCF Margin % for the quarter that ended in Dec. 2023 was 42.63%.

As of today, TalkMed Group's current FCF Yield % is 7.72%.

The historical rank and industry rank for TalkMed Group's FCF Margin % or its related term are showing as below:

SGX:5G3' s FCF Margin % Range Over the Past 10 Years
Min: 36.86 Med: 45.83 Max: 64.67
Current: 48.96

During the past 12 years, the highest FCF Margin % of TalkMed Group was 64.67%. The lowest was 36.86%. And the median was 45.83%.

SGX:5G3's FCF Margin % is ranked better than
98.49% of 663 companies
in the Healthcare Providers & Services industry
Industry Median: 1.44 vs SGX:5G3: 48.96

TalkMed Group FCF Margin % Historical Data

The historical data trend for TalkMed Group's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TalkMed Group FCF Margin % Chart

TalkMed Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

44.46

47.19

36.86

43.04

48.96

TalkMed Group Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Margin %	Get a 7-Day Free Trial															35.99	44.82	41.73	56.66	42.63

Competitive Comparison of TalkMed Group's FCF Margin %

For the Medical Care Facilities subindustry, TalkMed Group's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TalkMed Group's FCF Margin % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, TalkMed Group's FCF Margin % distribution charts can be found below:

* The bar in red indicates where TalkMed Group's FCF Margin % falls into.

TalkMed Group FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

TalkMed Group's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	41.022	/	83.792
	=	48.96 %

TalkMed Group's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	19.608	/	45.997
	=	42.63 %

TalkMed Group FCF Margin % Related Terms

Thank you for viewing the detailed overview of TalkMed Group's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

TalkMed Group (SGX:5G3) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » TalkMed Group Ltd (SGX:5G3) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

3 Mount Elizabeth, Mount Elizabeth Hospital Level 2, Singapore, SGP, 228510

Website

https://www.talkmed.com.sg

TalkMed Group Ltd operates as an investment holding company. It is a provider of medical oncology, stem cell transplants and palliative care services, serving patients in Singapore and the region. Outside Singapore, the Group operates in Vietnam, Hong Kong and the People's Republic of China. The activities of the company are the provision of medical oncology services and palliative care healthcare services in Singapore. It is organized into three reportable operating segments, Oncology Services, Stem Cells Services and Cellular and gene therapy-related products and services. The company has operational footprints across Singapore, Hong Kong and Vietnam of which Singapore contributes the vast majority of total revenue. It generates maximum revenue from the Oncology services segment.

TalkMed Group (SGX:5G3) Headlines

No Headlines